Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ?? Live and Webcast Investor Event with Fulcrum Lea ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients with SCD Iadademstat has demonstrated a favorable ...

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...

Placental growth factor shows 100% accuracy for early preeclampsia detection in sickle cell disease, new research indicates.

Electronic medical records of 42 children with SCD diagnosed between 2009 and 2023 were retrospectively reviewed. Clinical demographic data and pneumococcal serologies were analysed. Of the 42 ...

Life expectancy has soared and interest in the disease is growing, but breakthrough gene therapies are extraordinarily ...

NYU researchers partnered with Nigerian singer Adekunle Gold to launch an organization that uses music to reduce stigma and ...

After four years of battling a severe blood disease, five-year-old Zion Ortiz is finally free of sickle cell anemia.